$CVS
CVS HEALTH Corp

2012 Q2 Form 10-Q Financial Statement

#000110465912055261 Filed on August 07, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue $30.69B $26.41B
YoY Change 16.2% 11.37%
Cost Of Revenue $25.27B $21.33B
YoY Change 18.46% 13.97%
Gross Profit $5.443B $5.086B
YoY Change 7.02% 1.64%
Gross Profit Margin 17.73% 19.25%
Selling, General & Admin $3.741B $3.602B
YoY Change 3.86% 2.45%
% of Gross Profit 68.73% 70.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.741B $3.602B
YoY Change 3.86% 2.45%
Operating Profit $1.702B $1.484B
YoY Change 14.69% -0.27%
Interest Expense $132.0M $149.0M
YoY Change -11.41% -211.19%
% of Operating Profit 7.76% 10.04%
Other Income/Expense, Net
YoY Change
Pretax Income $1.576B $1.336B
YoY Change 17.96% -1.33%
Income Tax $610.0M $523.0M
% Of Pretax Income 38.71% 39.15%
Net Earnings $961.0M $815.0M
YoY Change 17.91% -0.73%
Net Earnings / Revenue 3.13% 3.09%
Basic Earnings Per Share $0.75 $0.60
Diluted Earnings Per Share $0.75 $0.60
COMMON SHARES
Basic Shares Outstanding 1.278B shares 1.355B shares
Diluted Shares Outstanding 1.287B shares 1.364B shares

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.828B $2.233B
YoY Change -18.14% 100.99%
Cash & Equivalents $1.823B $2.228B
Short-Term Investments $5.000M $5.000M
Other Short-Term Assets $919.0M $829.0M
YoY Change 10.86% 23.92%
Inventory $10.43B $10.11B
Prepaid Expenses
Receivables $6.124B $5.892B
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.30B $19.07B
YoY Change 1.23% 10.39%
LONG-TERM ASSETS
Property, Plant & Equipment $8.614B $8.483B
YoY Change 1.54% 2.85%
Goodwill $26.43B
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.360B $1.220B
YoY Change 11.48% 216.88%
Total Long-Term Assets $46.29B $46.42B
YoY Change -0.28% 4.9%
TOTAL ASSETS
Total Short-Term Assets $19.30B $19.07B
Total Long-Term Assets $46.29B $46.42B
Total Assets $65.59B $65.49B
YoY Change 0.16% 6.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.551B $7.507B
YoY Change 13.91% 18.24%
Accrued Expenses $4.380B $3.329B
YoY Change 31.57% 27.89%
Deferred Revenue
YoY Change
Short-Term Debt $200.0M $0.00
YoY Change -100.0%
Long-Term Debt Due $5.000M $916.0M
YoY Change -99.45% 39.85%
Total Short-Term Liabilities $13.14B $11.75B
YoY Change 11.78% 2.56%
LONG-TERM LIABILITIES
Long-Term Debt $9.208B $10.17B
YoY Change -9.44% 7.55%
Other Long-Term Liabilities $1.438B $1.343B
YoY Change 7.07% 25.51%
Total Long-Term Liabilities $10.65B $11.51B
YoY Change -7.51% 9.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.14B $11.75B
Total Long-Term Liabilities $10.65B $11.51B
Total Liabilities $27.68B $27.24B
YoY Change 1.59% 6.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 385.0M shares
Shareholders Equity $37.91B $38.24B
YoY Change
Total Liabilities & Shareholders Equity $65.59B $65.49B
YoY Change 0.16% 6.44%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income $961.0M $815.0M
YoY Change 17.91% -0.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.231B $1.207B
YoY Change 1.99% 85.12%
INVESTING ACTIVITIES
Capital Expenditures -$442.0M -$401.0M
YoY Change 10.22% -13.76%
Acquisitions
YoY Change
Other Investing Activities -$200.0M -$1.366B
YoY Change -85.36% 7488.89%
Cash From Investing Activities -$642.0M -$1.767B
YoY Change -63.67% 265.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -977.0M 626.0M
YoY Change -256.07% -674.31%
NET CHANGE
Cash From Operating Activities 1.231B 1.207B
Cash From Investing Activities -642.0M -1.767B
Cash From Financing Activities -977.0M 626.0M
Net Change In Cash -388.0M 66.00M
YoY Change -687.88% 10.0%
FREE CASH FLOW
Cash From Operating Activities $1.231B $1.207B
Capital Expenditures -$442.0M -$401.0M
Free Cash Flow $1.673B $1.608B
YoY Change 4.04% 43.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
dei Entity Registrant Name
EntityRegistrantName
CVS CAREMARK CORP
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2011Q2 us-gaap Revenues
Revenues
26414000000 USD
CY2011Q2 us-gaap Cost Of Revenue
CostOfRevenue
21328000000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
5086000000 USD
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
3602000000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1484000000 USD
CY2011Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-148000000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1336000000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
523000000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
813000000 USD
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2000000 USD
CY2011Q2 us-gaap Profit Loss
ProfitLoss
815000000 USD
CY2011Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
816000000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.60
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1355000000 shares
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.60
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1364000000 shares
CY2011Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
us-gaap Revenues
Revenues
52109000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
42281000000 USD
us-gaap Gross Profit
GrossProfit
9828000000 USD
us-gaap Operating Expenses
OperatingExpenses
7039000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2789000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-282000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2507000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
985000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1522000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
5000000 USD
us-gaap Profit Loss
ProfitLoss
1527000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1529000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
805000000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
806000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1359000000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.11
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1368000000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1708000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1576000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
966000000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
966000000 USD
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.325
us-gaap Gross Profit
GrossProfit
10562000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3111000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2848000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1742000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1742000000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1517000000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1519000000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
965000000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
966000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1741000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1743000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1413000000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6047000000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
10046000000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
503000000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
580000000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
18594000000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8467000000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
26458000000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9869000000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1155000000 USD
CY2011Q4 us-gaap Assets
Assets
64543000000 USD
CY2012Q2 us-gaap Assets
Assets
65589000000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4370000000 USD
CY2011Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3487000000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3293000000 USD
CY2011Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
750000000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
56000000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11956000000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9208000000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3853000000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1445000000 USD
CY2011Q4 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
30000000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
16000000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11953000000 USD
CY2011Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
56000000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28126000000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38051000000 USD
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
385000000 shares
CY2012Q2 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
2000000 shares
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22090000000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-172000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3073000000 USD
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64543000000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
56000000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65589000000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13136000000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
19299000000 USD
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1658000000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1271000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1640000000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1298000000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
340000000 shares
CY2011Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
2000000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4017000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1085000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2522000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
47950000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
37307000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
6149000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
710000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
11000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1366000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2000000 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2066000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-300000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1463000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
302000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
341000000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
19000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
264000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
971000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-206000000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1427000000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2228000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
765000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
65000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
129000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
472000000 USD
us-gaap Interest Paid
InterestPaid
298000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1125000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-584000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
164000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1200000000 USD
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1287000000 shares
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
62000000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1298000000 shares
cvs Reporting Segments Number
ReportingSegmentsNumber
3 item
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29200000 shares
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
722000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
54000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-75000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.76
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.35
cvs Minimum Initial Maturities Of Short Term Investments
MinimumInitialMaturitiesOfShortTermInvestments
3 month
CY2012Q2 us-gaap Long Term Debt
LongTermDebt
9200000000 USD
CY2012Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
10800000000 USD
CY2012Q2 cvs Percentage Of Consolidated Inventories Affected Due To Change In Accounting Principle
PercentageOfConsolidatedInventoriesAffectedDueToChangeInAccountingPrinciple
0.51 pure
CY2012Q2 us-gaap Interest Expense
InterestExpense
132000000 USD
us-gaap Interest Expense
InterestExpense
264000000 USD
CY2011Q2 us-gaap Interest Expense
InterestExpense
149000000 USD
us-gaap Interest Expense
InterestExpense
284000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2012Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-132000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-263000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2000000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000 shares
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34600000 shares
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.75
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
CY2012Q2 us-gaap Revenues
Revenues
30714000000 USD
us-gaap Revenues
Revenues
61512000000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
5449000000 USD
CY2012Q2 cvs Guaranteed Store Leases
GuaranteedStoreLeases
76 item
cvs Number Of Adjudication Platforms Under Investigation
NumberOfAdjudicationPlatformsUnderInvestigation
2 item
CY2003Q4 cvs Number Of Pharmacies Filing Putative Action
NumberOfPharmaciesFilingPutativeAction
2 item
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1278000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1289000000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2011Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2012Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2011Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
2000000 shares
CY2012Q2 us-gaap Goodwill
Goodwill
26425000000 USD
CY2012Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
840000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1600000000 USD
CY2011Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
626000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
967000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1744000000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
814000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1524000000 USD
CY2003Q4 cvs Number Of Competitors Against Whom Putative Actions Are Filed
NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled
2 item
CY2003Q4 cvs Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 item
cvs Number Of States Participating In Multistate Investigations
NumberOfStatesParticipatingInMultistateInvestigations
28 item
CY2011Q1 cvs Number Of Additional Subpoenas Received
NumberOfAdditionalSubpoenasReceived
2 item
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
49000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.54
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
4.33 year
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
7000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.14
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
45.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0

Files In Submission

Name View Source Status
0001104659-12-055261-index-headers.html Edgar Link pending
0001104659-12-055261-index.html Edgar Link pending
0001104659-12-055261.txt Edgar Link pending
0001104659-12-055261-xbrl.zip Edgar Link pending
a12-13824_110q.htm Edgar Link pending
a12-13824_1ex15d1.htm Edgar Link pending
a12-13824_1ex31d1.htm Edgar Link pending
a12-13824_1ex31d2.htm Edgar Link pending
a12-13824_1ex32d1.htm Edgar Link pending
a12-13824_1ex32d2.htm Edgar Link pending
cvs-20120630.xml Edgar Link completed
cvs-20120630.xsd Edgar Link pending
cvs-20120630_cal.xml Edgar Link unprocessable
cvs-20120630_def.xml Edgar Link unprocessable
cvs-20120630_lab.xml Edgar Link unprocessable
cvs-20120630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending